Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents

NCT02402933 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoglycemia
Diabetes Mellitus

Interventions

DRUG: Nasal Glucagon

Sponsor

Eli Lilly and Company